Revolution Medicines (RVMD) Other Non Operating Income (2024 - 2026)

Revolution Medicines has reported Other Non Operating Income for 3 years, with the latest figure at $117000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 1270.0% year-over-year to $117000.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 155.57% YoY), and the FY2025 full-year result was $1.3 million, changed N/A from the prior year.
• Other Non Operating Income for Q1 2026 stood at $117000.0, down from $1.3 million in the prior quarter.
• The five-year high for Other Non Operating Income was $1.3 million in Q4 2025, with the low at -$2.8 million in Q1 2024.
• Average Other Non Operating Income over 3 years is -$185000.0, with a median of $66500.0 recorded in 2024.
• Year-over-year, Other Non Operating Income soared 99.64% in 2025 and soared 1270.0% in 2026.
• Tracing RVMD's Other Non Operating Income over 3 years: stood at $282000.0 in 2024, then jumped by 358.87% to $1.3 million in 2025, then sank by 90.96% to $117000.0 in 2026.
• The last three Other Non Operating Income figures came in at $117000.0 (Q1 2026), $1.3 million (Q4 2025), and -$10000.0 (Q1 2025), per Business Quant data.

Peer Comparison